Sumatriptan. 3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide . GR-43175 . Imigran . Sumatriptan Succinate . GR 43175 . GR43175 . Succinate, Sumatriptan . A serotonin agonist that acts selectively at 5HT1 receptors. It is used in the treatment of MIGRAINE DISORDERS. . 1.00
Anistreplase. BRL-26921 . Eminase . Iminase . BRL 26921 . BRL26921 . Anisoylated Plasminogen-Streptokinase Activator Complex . APSAC . An acylated inactive complex of streptokinase and human lysine-plasminogen. After injection, the acyl group is slowly hydrolyzed, producing an activator that converts plasminogen to plasmin, thereby initiating fibrinolysis. Its half-life is about 90 minutes compared to 5 minutes for TPA; (TISSUE PLASMINOGEN ACTIVATOR); 16 minutes for UROKINASE-TYPE PLASMINOGEN ACTIVATOR and 23 minutes for STREPTOKINASE. If treatment is initiated within 3 hours of onset of symptoms for acute myocardial infarction, the drug preserves myocardial tissue and left ventricular function and increases coronary artery patency. Bleeding complications are similar to other thrombolytic agents. . 0.62
Phosmet. Imidan . N-(Mercaptomethyl)phthalimide S-(O,O-dimethyl phosphorothionate) . Prolate . Phthalophos . An organothiophosphorus insecticide that has been used to control pig mange. . 0.60
Imipramine. Imipramine Hydrochloride . Imipramine Monohydrochloride . Janimine . Melipramine . Norchlorimipramine . Pryleugan . Tofranil . Imidobenzyle . Imizin . The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group. . 0.57
Imidoesters. Imidates . Esters of the hypothetical imidic acids. They react with amines or amino acids to form amidines and are therefore used to modify protein structures and as cross-linking agents. . 0.57